Literature DB >> 22038252

Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania.

Matthew B Rogers1, James D Hilley, Nicholas J Dickens, Jon Wilkes, Paul A Bates, Daniel P Depledge, David Harris, Yerim Her, Pawel Herzyk, Hideo Imamura, Thomas D Otto, Mandy Sanders, Kathy Seeger, Jean-Claude Dujardin, Matthew Berriman, Deborah F Smith, Christiane Hertz-Fowler, Jeremy C Mottram.   

Abstract

Leishmania parasites cause a spectrum of clinical pathology in humans ranging from disfiguring cutaneous lesions to fatal visceral leishmaniasis. We have generated a reference genome for Leishmania mexicana and refined the reference genomes for Leishmania major, Leishmania infantum, and Leishmania braziliensis. This has allowed the identification of a remarkably low number of genes or paralog groups (2, 14, 19, and 67, respectively) unique to one species. These were found to be conserved in additional isolates of the same species. We have predicted allelic variation and find that in these isolates, L. major and L. infantum have a surprisingly low number of predicted heterozygous SNPs compared with L. braziliensis and L. mexicana. We used short read coverage to infer ploidy and gene copy numbers, identifying large copy number variations between species, with 200 tandem gene arrays in L. major and 132 in L. mexicana. Chromosome copy number also varied significantly between species, with nine supernumerary chromosomes in L. infantum, four in L. mexicana, two in L. braziliensis, and one in L. major. A significant bias against gene arrays on supernumerary chromosomes was shown to exist, indicating that duplication events occur more frequently on disomic chromosomes. Taken together, our data demonstrate that there is little variation in unique gene content across Leishmania species, but large-scale genetic heterogeneity can result through gene amplification on disomic chromosomes and variation in chromosome number. Increased gene copy number due to chromosome amplification may contribute to alterations in gene expression in response to environmental conditions in the host, providing a genetic basis for disease tropism.

Entities:  

Mesh:

Year:  2011        PMID: 22038252      PMCID: PMC3227102          DOI: 10.1101/gr.122945.111

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  55 in total

1.  Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.

Authors:  S Stäger; D F Smith; P M Kaye
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

2.  SSAHA: a fast search method for large DNA databases.

Authors:  Z Ning; A J Cox; J C Mullikin
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

3.  The origins of genome complexity.

Authors:  Michael Lynch; John S Conery
Journal:  Science       Date:  2003-11-21       Impact factor: 47.728

4.  Screening Leishmania donovani-specific genes required for visceral infection.

Authors:  Wen-Wei Zhang; Greg Matlashewski
Journal:  Mol Microbiol       Date:  2010-06-01       Impact factor: 3.501

5.  The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.

Authors:  Nancy Noben-Trauth; Rosalia Lira; Hisashi Nagase; William E Paul; David L Sacks
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

6.  The Leishmania genome comprises 36 chromosomes conserved across widely divergent human pathogenic species.

Authors:  P Wincker; C Ravel; C Blaineau; M Pages; Y Jauffret; J P Dedet; P Bastien
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

7.  Transcription of Leishmania major Friedlin chromosome 1 initiates in both directions within a single region.

Authors:  Santiago Martínez-Calvillo; Shaofeng Yan; Dan Nguyen; Mark Fox; Kenneth Stuart; Peter J Myler
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

8.  Plasticity in chromosome number and testing of essential genes in Leishmania by targeting.

Authors:  A K Cruz; R Titus; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

9.  Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.

Authors:  D J Bradley; J Kirkley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

10.  OrthoMCL: identification of ortholog groups for eukaryotic genomes.

Authors:  Li Li; Christian J Stoeckert; David S Roos
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

View more
  194 in total

1.  Modulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase.

Authors:  Goutam Mandal; Mansi Sharma; Martin Kruse; Claudia Sander-Juelch; Laura A Munro; Yong Wang; Jenny Veide Vilg; Markus J Tamás; Hiranmoy Bhattacharjee; Martin Wiese; Rita Mukhopadhyay
Journal:  Mol Microbiol       Date:  2012-07-26       Impact factor: 3.501

2.  Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.

Authors:  Juvana M Andrade; Elio H Baba; Ricardo A Machado-de-Avila; Carlos Chavez-Olortegui; Cynthia P Demicheli; Frédéric Frézard; Rubens L Monte-Neto; Silvane M F Murta
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

3.  Reproductive clonality of pathogens: a perspective on pathogenic viruses, bacteria, fungi, and parasitic protozoa.

Authors:  Michel Tibayrenc; Francisco J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

4.  Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.

Authors:  Douglas R Rice; Paola Vacchina; Brianna Norris-Mullins; Miguel A Morales; Bradley D Smith
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 5.  The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Authors:  Mary-Anne Hartley; Stefan Drexler; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Trends Parasitol       Date:  2014-06-20

Review 6.  DNA repair pathways in trypanosomatids: from DNA repair to drug resistance.

Authors:  Marie-Michelle Genois; Eric R Paquet; Marie-Claude N Laffitte; Ranjan Maity; Amélie Rodrigue; Marc Ouellette; Jean-Yves Masson
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

7.  Comparative genomics of canine-isolated Leishmania (Leishmania) amazonensis from an endemic focus of visceral leishmaniasis in Governador Valadares, southeastern Brazil.

Authors:  Hugo O Valdivia; Laila V Almeida; Bruno M Roatt; João Luís Reis-Cunha; Agnes Antônia Sampaio Pereira; Celia Gontijo; Ricardo Toshio Fujiwara; Alexandre B Reis; Mandy J Sanders; James A Cotton; Daniella C Bartholomeu
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

8.  Northalrugosidine is a bisbenzyltetrahydroisoquinoline alkaloid from Thalictrum alpinum with in vivo antileishmanial activity.

Authors:  C Benjamin Naman; Gaurav Gupta; Sanjay Varikuti; Heebyung Chai; Raymond W Doskotch; Abhay R Satoskar; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2015-01-28       Impact factor: 4.050

9.  Global genome diversity of the Leishmania donovani complex.

Authors:  Susanne U Franssen; Caroline Durrant; Olivia Stark; Bettina Moser; Tim Downing; Hideo Imamura; Jean-Claude Dujardin; Mandy J Sanders; Isabel Mauricio; Michael A Miles; Lionel F Schnur; Charles L Jaffe; Abdelmajeed Nasereddin; Henk Schallig; Matthew Yeo; Tapan Bhattacharyya; Mohammad Z Alam; Matthew Berriman; Thierry Wirth; Gabriele Schönian; James A Cotton
Journal:  Elife       Date:  2020-03-25       Impact factor: 8.140

10.  Phosphoglycerate kinase: structural aspects and functions, with special emphasis on the enzyme from Kinetoplastea.

Authors:  Maura Rojas-Pirela; Diego Andrade-Alviárez; Verónica Rojas; Ulrike Kemmerling; Ana J Cáceres; Paul A Michels; Juan Luis Concepción; Wilfredo Quiñones
Journal:  Open Biol       Date:  2020-11-25       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.